VANGUARD GROUP INC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is and the CUSIP is 91381U200. A total of 46 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$1,347,845
-6.1%
561,602
-0.2%
0.00%
Q2 2023$1,435,543
+68.1%
562,958
+7.5%
0.00%
Q1 2023$853,996
-29.8%
523,924
+18.0%
0.00%
Q4 2022$1,216,077443,8240.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 49,172$118,01314.70%
ARCH Venture Management, LLC 1,004,817$2,411,5611.57%
Mayo Clinic 124,081$297,7940.57%
Alyeska Investment Group, L.P. 1,286,000$3,086,4000.02%
UBS OCONNOR LLC 179,080$429,7920.01%
Cercano Management LLC 41,238$98,9710.00%
Johnson Midwest Financial, LLC 661$1,5860.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 50,000$120,0000.00%
Alyeska Investment Group, L.P. 38,695$92,8680.00%
Laurion Capital Management LP 70,000$168,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders